Related News
Lanxess AG expands global portfolio, business in China market
Print Edition
Lanxess AG has stood the test of the COVID-19 pandemic, thanks to its increasingly enriched business portfolio and greater global presence outside of Europe.
While many companies are struggling to overcome the virus, Lanxess has confidently released its financial target for this year despite facing many uncertainties. When many companies are cutting spending, Lanxess continues investing in China and its Asia application center broke ground in July as scheduled.
These achievements are thanks to Lanxess鈥 long-term strategy to broaden its presence and optimize its business, according to Ming Cheng Chien, president for Asia-Pacific region at Lanxess.
鈥淪ince its beginning, Lanxess has never stopped optimizing its business. About 10 years ago, Lanxess was the world鈥檚 largest rubber producer, which has one obvious weakness, that is its near-total dependency on the automotive industry,鈥 Chien said.
鈥淪o four or five years ago, we started to change it. At that time, the rubber unit was a big chunk of Lanxess鈥 business portfolio, about 40 percent,鈥 Chien said.
In 2018, Lanxess completely sold its rubber business to Saudi Aramco, the Saudi Arabian multinational petroleum and natural gas company based in Dhahran, Saudi Arabia, for 2.6 billion euros (US$3 billion).
鈥淭iming is good. When the pandemic hit us and the automotive industry was heavily affected, we were not so significantly affected, thanks to Lanxess鈥 wider portfolio of products,鈥 Chien said.
Lanxess鈥 other long-term strategy of increasing global presence also worked to help it overcome the pandemic. As a German specialty chemicals company headquartered in Cologne, Germany, Lanxess has been doing a lot of business in Europe.
For now, Europe is still the biggest sales market for Lanxess, accounting for almost half of its total revenue, while the Asia Pacific makes up less than one fourth. Lanxess鈥 target is to balance its global presence, namely obtaining roughly similar revenues from Europe, the Americas and the Asia Pacific.
The company is continuously increasing its presence in China since its spin-off from Bayer AG, and it paid off, according to Chien.
鈥淚f we did not have our business in China, we would see a much worse situation,鈥 he said. 鈥淎nd especially from this experience amid the pandemic and the complex geopolitics, we really need to increase domestic supply chain, and a global presence is very important.鈥
In July, the company鈥檚 application center was built for making products for the Asia Pacific, especially for China.
鈥淟anxess has already realized we cannot produce standard products for all regions. Very often, we have to make products for certain markets. China鈥檚 demands are different from others and China would require products for China,鈥 he added.
鈥淒isinfectants and products about food safety are all our strategy here as we see high demand of these products in China,鈥 Chien added.
鈥淲e will also look into long-term applications, such as e-mobility and batteries. So we would use the application center to produce products which are most suitable for China. I am very confident our investment would pay off in the long term,鈥 Chien said.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
